All cases expressed an EWS-FLI1 or EWS-ERG fusion gene and were part of the NCI Strategic Partnering to Evaluate Cancer Signatures (SPECS) program for childhood sarcoma gene expression profiling (49). The gene discussed is ERG; the disease is cancer.